Thalamus Biosciences

Book a 30-minute call

Imaging Science, End to End

Thalamus Biosciences advises drug discovery teams on imaging, from the first decision to the final analysis. We advise upfront on the choice of microscope and modality, on the design of imaging assays for 2D, 3D, organoid and tissue work, and on screening and validation. We then carry out image analysis as a service, and we advise on the discovery biology around the imaging.

The experience behind Thalamus Biosciences

Practice areas

Imaging advisory

We advise before the imaging work begins. The advice covers the choice of microscope and modality, the design of imaging assays for 2D, 3D, organoid and tissue work, and screening and validation.

Image analysis services

We analyze images from cell-based assays, including 3D and organoid models, and from tissue sections (immunofluorescence and multiplex IF). We also set up analysis in a client's own laboratory and review existing analyses.

Imaging and instrument companies

We work with microscope, imaging and reagent companies on application science, on validation studies and on technical writing for pharma scientists.

Discovery biology programs

We also lead or support the biology around the imaging. This work covers the in vitro biology of drug discovery programs, from the assay cascade and the cell models to the CRO studies and the review of data packages, and it draws on experience of leading the biology on a pharma program.

How we work

Start with a 30-minute call

On the call we discuss your program or product and the decision you need to make, and you receive an initial assessment.

Book a 30-minute call